OpenLegislation

Part 2 Capital Fees for Pre-Application MeetingsF1

Repealed

  1. 3Interpretation of Part 2
  2. 4Fee for scientific advice: application for, or variation to, EU marketing authorization
  3. 5Fee for scientific advice: classification of a medicinal product
  4. 6Fee for advertising advice
  5. 7Fee for pharmacovigilance advice
  6. 8Fee for advice on labelling or leaflets
  7. 9Fee for regulatory advice
  8. 10Fee for advice for other purposes
  9. 11Time for payment of fees under regulations 4 to 10

Annotations

Textual amendments

F1

Regulations revoked (1.4.2012) by The Medicines (Products for Human Use) (Fees) Regulations 2012 (S.I. 2012/504), regs. 1, 57(1) (with reg. 57(2)-(4)) and Regulations expressed to be revoked (N.I.) (1.4.2012) by The Medicines (Products for Human Use) (Fees) Regulations 2012 (S.R. 2012/134), regs. 1, 57 (with reg. 57(2)-(4))